Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Invested Capital (2020 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Invested Capital for 4 consecutive years, with 0.05% as the latest value for Q1 2021.

  • On a quarterly basis, Return on Invested Capital fell 91.0% to 0.05% in Q1 2021 year-over-year; TTM through Mar 2021 was 0.05%, a 91.0% decrease, with the full-year FY2020 number at 0.05%, down 109.0% from a year prior.
  • Return on Invested Capital was 0.05% for Q1 2021 at Creative Medical Technology Holdings, down from 0.55% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.02% in Q4 2019 to a low of 0.05% in Q1 2021.
  • A 4-year average of 0.56% and a median of 0.53% in 2019 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: soared 75bps in 2019, then tumbled -91bps in 2021.
  • Creative Medical Technology Holdings' Return on Invested Capital stood at 0.27% in 2018, then soared by 277bps to 1.02% in 2019, then crashed by -46bps to 0.55% in 2020, then crashed by -91bps to 0.05% in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Return on Invested Capital are 0.05% (Q1 2021), 0.55% (Q3 2020), and 0.97% (Q1 2020).